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OBJECTIVE: The purpose of this case-control study was to evaluate risk factors associated with death in children
with severe dengue.
METHODS: The clinical condition of hospitalized patients with severe dengue who died (cases, n = 18) was
compared with that of hospitalized patients with severe dengue who survived (controls, n = 77). The inclusion
criteria for this study were age under 13 years; hospital admission in Sa˜o Luis, northeastern Brazil; and
laboratory-confirmed diagnosis of dengue.
RESULTS: Severe bleeding (hemoptysis), a defining criterion for dengue severity, was the factor most strongly
associated with death in our study. We also found that epistaxis and persistent vomiting, both included as
warning signs in the World Health Organization (WHO) classification of dengue, were strongly associated with
death. No significant association was observed between any of the laboratory findings and death.
CONCLUSIONS: The finding that epistaxis and persistent vomiting were also associated with death in children
with severe dengue was unexpected and deserves to be explored in future studies. Because intensive care units
are often limited in resource-poor settings, any information that can help to distinguish patients with severe
dengue with a higher risk to progress to death may be crucial.
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& INTRODUCTION
The incidence of dengue virus infection is rising in
endemic areas in tropical and subtropical regions world-
wide. In the Americas, the cumulative number of dengue
cases in the last 30 years exceeded 5 million. In this time
period, Brazil had the largest number of reported dengue
cases (54.5% of those reported in the Americas) and the sixth
largest number of dengue hemorrhagic fever (DHF) cases
(1). In Brazil, the first dengue outbreak occurred in 1981-
1982, in Boa Vista, Roraima State, with isolation of the
DENV-1 and DENV-4 serotypes (2). This outbreak was
contained by local vector control measures, and no dengue
activity was reported for the next 4 years (3). In 1986, the
DENV-1 serotype was introduced into Rio de Janeiro. Since
the re-emergence of dengue in Brazil in 1986, the country
has had several epidemics and has reported the highest
number of cases in the world on multiple occasions (4). In
the Americas, the dengue case-fatality rate has increased
over the past decade (1). The incidence of severe cases of
dengue in Brazil has increased since 2001 (3,5), with a
dramatic increase in severe cases and dengue-related deaths
in patients younger than 15 years of age since 2007,
particularly in the northeastern region of the country (6-7).
Three serotypes of dengue virus (DENV-1, DENV-2, and
DENV-3) have been endemic in Brazil since 2000 (4,8).
Endemic circulation of the fourth serotype (DENV-4) has
recently also been confirmed in Brazil (9-10). In the
northeastern state of Maranha˜o, high household infestation
rates of Aedes aegypti have been observed since 1995,
particularly on Sa˜o Luı´s Island (11). The first few cases of
dengue caused by DENV-1 in Maranha˜o were reported in
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1994, followed by outbreaks in 1995-96 and 1997-98 (12). A
seroepidemiologic survey conducted in 1996 revealed a
41.5% prevalence of dengue antibodies among residents of
Sa˜o Luı´s Island (13). After the introduction of DENV-2 into
Maranha˜o in 2001, the incidence of dengue in the state
increased (12); however, the first deaths from DHF only
occurred after the introduction of DENV-3 (5,12). An
increase in the incidence of DHF and an increase in case-
fatality rates in children under age 15 during a 2006-2007
epidemic were predominantly associated with infection
with the DENV-2 serotype. The risk factors for DHF and for
dengue shock syndrome (DSS) in children have been
addressed in previous studies (14-20). However, most
clinical and laboratory findings associated with death in
children have been compiled through descriptive studies. In
this case-control study, we report the risk factors associated
with death in dengue patients younger than 13 years.
& MATERIALS AND METHODS
Study design and patients
This study was performed in Sa˜o Luı´s, the capital of the
northeastern Brazilian state of Maranha˜o. The inclusion
criteria for this study were age under 13 years and hospital
admission in Sa˜o Luis with laboratory-confirmed acute
dengue infection. The patients who died (n = 18) were
selected among patients admitted to any hospital in Sa˜o
Luı´s from April 2006 (the beginning of the epidemic)
through December 2007. The controls (n = 77) were all
patients with severe dengue admitted to the Hospital of the
Universidade Federal do Maranha˜o (HUUFMA) during the
same period who survived. The controls were selected only
in the HUUFMA because it is a state referral hospital for the
treatment of severe and complicated dengue cases where
reliable medical records were available. It is a public
hospital that is part of the national public health system.
Additionally, we conducted a subset analysis, considering
only the cases admitted to the HUUFMA.
Laboratory diagnosis of acute dengue infection
The diagnosis of acute dengue infection was confirmed by
detection of dengue-specific IgM antibodies using an
immunoglobulin M antibody-capture enzyme-linked immu-
nosorbent assay (MAC-ELISA) or by DENV detection in
serum, blood, or viscera by reverse transcription-polymer-
ase chain reaction (RT-PCR). These tests were conducted in
a Central Public Health Reference Laboratory.
Dengue case classification
The 2009 World Health Organization (WHO) ‘‘Dengue
guidelines for diagnosis, treatment, prevention, and con-
trol’’ document was used for dengue case classification and
for determining levels of severity. In this classification,
severe dengue is defined by the presence of severe plasma
leakage leading to shock or fluid accumulation with
respiratory distress; and/or severe bleeding, as evaluated
by the clinician; and/or severe organ involvement (liver,
central nervous system [CNS], heart and other organs) (21).
Clinical and laboratory data
Demographics, medical history, clinical findings, results
of laboratory tests and imaging as well as information
about treatment and patient outcomes were obtained from
medical records and investigation forms of the National
Mandatory Reporting System (SINAN) for dengue cases.
Patients who died were identified through data available
in three different systems: the SINAN, the Mortality
Information System (SIM) and the Hospital Admission
Information System of the National Public Health System
(SIH-SUS). Additional clinical and pathological information
regarding fatal cases was obtained from death certificates,
necropsy reports and interviews with family members
compiled by the Municipal Dengue Control Program of
Sa˜o Luı´s.
The plasma leakage criteria were cavity effusion (found
on imaging or on necropsy), hemoconcentration (an increase
in hematocrit of $20% of baseline or a decrease in
hematocrit following volume-replacement treatment of
$20% of baseline), hypoalbuminemia (serum albumin
,3.5 g/dL) or hypoproteinemia (serum protein,6.0 g/dL).
Data analysis
Clinical and laboratory data were entered into a database
using Epi Info 3.5 software (Centers for Disease Control and
Prevention, Atlanta, GA, USA). STATA 10.0 software
(StataCorp LP, College Station, TX, USA) was used for
statistical analysis. For quantitative variables, measures of
central tendency and dispersion were calculated.
Qualitative variables are presented as frequencies and
proportions. A logistic regression model was used to
calculate the unadjusted associations between the outcome
(death) and various independent variables. Odds ratios and
95% confidence intervals were calculated. The number of
cases was too small to allow for adjustment in a multiple
logistic regression model.
Ethics
The study protocol was approved by the Institutional
Review Board of the HUUFMA. Sources included informa-
tion obtained from medical records, death certificates,
necropsy reports and SINAN investigation forms.
Confidentiality and subject anonymity was ensured
throughout the investigation. Written informed consent
was not obtained because the study primarily relied on
secondary data. In interviews with the family members of
patients who died of dengue, oral consent was obtained and
documented.
& RESULTS
During the study period, 33 patients under 13 years of
age died of suspected dengue. Ten of these 33 patients
were admitted to the ICU of the HUUFMA, and 23 were
admitted to one of the seven other hospitals in Sa˜o Luı´s. Of
the 33 patients, 18 had laboratory-confirmed dengue
infection and were included in the study as cases. Thir-
teen of the remaining 15 patients who died could be
thoroughly investigated, and 4 had signs of severe plasma
leakage, suggesting severe dengue. However, because a
laboratory diagnosis of dengue could not be confirmed,
these 4 patients were not included in the study. Of the 18
cases included in the study, 5 were admitted to the ICU of
the HUUFMA.
Of 396 patients younger than 13 years with suspected
dengue who were admitted to the HUUFMA during the
study period, 77 had laboratory-confirmed dengue in its
most serious presentation (shock) and were included in
the study as controls. Demographic information, DENV
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serotypes, ICU admission and the durations of fever and
hospital stay are shown in Table 1. All cases and controls
had fever. The durations of fever and hospital stay were
shorter among cases than controls (Table 1).
Simple logistic regression analysis showed that epistaxis,
hemoptysis and persistent vomiting were clinical signs
significantly associated with death (Table 2). Table 3 shows
the laboratory and imaging results as well as the analysis of
the plasma leakage criteria (cavity effusion, hemoconcentra-
tion, hypoalbuminemia and hypoproteinemia). No signifi-
cant association was observed between any of the laboratory
findings and death.
To control for possible selection bias, we performed a
subset analysis including only the cases admitted to the
HUUFMA (Table 4). In this subset, most of the findings
were maintained. The association with ‘‘persistent vomit-
ing’’ was no longer significant; however, epistaxis remained
a significant factor associated with death.
& DISCUSSION
In our study, no significant association was observed
between any of the laboratory findings and death. This
finding supports the 2009 WHO dengue criteria for severe
dengue, which emphasize clinical signs over laboratory
findings (21). Severe plasma leakage leading to shock did
not appear to be a significant risk factor because all controls
had severe dengue with shock. The factor most strongly
associated with death in our study was severe bleeding
(hemoptysis). Hemoptysis is considered a defining criterion
for dengue severity, according to the revised WHO
classification (21) that was recently assessed in a multi-
center study (22). However, we found that epistaxis and
persistent vomiting, which are considered warning signs in
the revised WHO dengue case classification, were also
strongly associated with death. Epistaxis remained signifi-
cantly associated with death in the subset analysis including
only the cases admitted to the HUUFMA. From a clinical
point of view, epistaxis and persistent vomiting are not
intrinsically severe, unlike hemoptysis and shock, which can
cause a rapid progression of the patient to death. However,
epistaxis and persistent vomiting can be surrogate markers
for severe dengue, even if we do not currently have a logical
explanation for this finding.
Signs and symptoms associated with death in children
have been addressed in previous descriptive studies. In Thai
children, bleeding was one of the risk factors for DSS (17). In
Colombian children with DHF and atypical manifestations
of dengue, all those who had hemoptysis died (23). In
Malaysian children with severe dengue infections, a
significant association was found between major bleeding
and death (p= 0.001) (24). In an Indonesian study of 30
children with dengue who died, 16.7% had epistaxis (25). In
the 1981 Cuban epidemic, of the 13 children with DHF/DSS
who died, 12 had vomiting, and 3 had epistaxis (26).
In a descriptive study of 15 Colombian children younger
than 13 with DHF who died, the cause of death was
myocarditis in 9, acute hepatitis in 3 and disseminated
intravascular coagulation in the remaining 3, indicating that
mortality due to DHF was not caused only by hypovolemic
shock (27). Some information from the cited descriptive
Table 1 - Demographic and clinical features of children
with severe dengue.
Demographic or clinical feature Cases Controls
No. of patients 18 77
Time of occurrence
2006 3 44
2007 15 33
Boys, no. (%) 6 (33.3) 34 (44.2)
Admission to ICU, n (%) 11 (61.1) 12 (15.6)
Serotype (n) DENV-2 (5) (0)
Necropsy 6 0
Comorbidities 1 (5.5) 0
Suspected dengue on admission, n (%) 9/13 (69.2) 76/77 (98.7)
Age, mean years ¡ SD (median) 4.17¡3.29 (4) 4.04¡2.72 (4)
Age range in years 0-10 0-12
Age, minimum in months 6 4
Fever duration, mean days ¡ SD
(median)
3.77¡1.89 (3) 5.30¡2.53 (5)
Duration of fever, range in days 1-8 1-13
Hospital stay, mean days ¡ SD
(median)
2.20¡2.01 (2) 7.26¡3.63 (6)
Hospital stay, range in days 0-6 3-24
Table 2 - Association between clinical characteristics and death in children with severe dengue.
Signs and symptoms Cases N (%) Controls N (%) Odds ratio 95% CI p-value
Cold extremities 8/17 (47.1) 14/77 (18.2) 4.00 1.31-12.19 0.015
Cyanosis 10/17 (58.8) 17/77 (22.1) 5.04 1.67-15.24 0.004
Dehydration 14/15 (93.3) 53/77 (68.8) 6.34 0.79-51.01 0.083
Dyspnea 11/17 (64.7) 36/77 (46.7) 2.09 0.70-6.21 0.186
Edema 8/17 (47.1) 47/77 (61.0) 0.57 0.20-1.63 0.293
Lethargy 13/17 (76.5) 36/77 (46.7) 3.70 1.11-12.37 0.034
Persistent vomiting 7/17 (41.2) 11/77 (14.3) 4.20 1.32-13.37 0.015
Prostration 11/17 (64.7) 9/77 (11.7) 13.85 4.12-46.62 ,0.001
Restlessness 6/17 (35.3) 13/77 (16.9) 2.68 0.84-8.56 0.095
Shock 18/18 (100.0) 77/77 (100.0) NCa NC NC
Bleeding (any kind) 15/18 (83.3) 77/77 (100.0) NC NC NC
Ecchymoses 6/18 (33.3) 13/77 (16.9) 2.46 0.78-7.75 0.124
Epistaxis 5/17 (29.4) 7/77 (9.1) 4.17 1.13-15.3 0.032
Gastrointestinal bleeding 14/18 (77.8) 41/77 (53.3) 3.07 0.93-10.18 0.066
Gum bleeding 1/17 (5.9) 10/77 (13.0) 0.42 0.05-3.51 0.422
Hemoptysis 4/17 (23.5) 1/77 (1.3) 23.38 2.42-226.1 0.006
Petechiae 6/18 (33.3) 54/77 (70.1) 0.21 0.07-0.64 0.006
Positive tourniquet test 1/3 (33.3) 15/31 (48.4) 0.53 0.04-6.51 0.622
aNC = not calculated.
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studies on death in children with dengue is summarized in
Table 5.
The DENV-2 serotype predominated in Maranha˜o in 2006
and 2007. Unfortunately, genotyping was not performed for
all patients in the outbreak in Sa˜o Luı´s; the DENV serotype
was determined in only 5 cases, and all 5 were DENV-2.
In our study, different factors may have contributed to the
poor prognosis of the cases. The pediatricians had no
experience in the diagnosis and management of patients
with dengue, and health teams were not prepared to
provide emergency care to patients with severe dengue
during the early phase of the epidemic. Only 69.2% of cases
were diagnosed as dengue at the time of hospital admission,
compared to 98.7% of controls. This finding suggests that a
delay in dengue diagnosis may have worsened the prog-
nosis. Additionally, 5 patients had no access to an ICU bed,
and 2 arrived at the hospital with advanced disease. Similar
findings were observed in a descriptive study on 14 deaths
due to dengue in 2 municipalities in northeastern Brazil (30).
The durations of fever and hospital stay were shorter in
cases than in controls, suggesting that the clinical condition
of the cases on admission was worse than that of the
controls, which may have contributed to the worse out-
comes observed for the cases. It is important to consider that
the earlier a risk factor for death can be identified, the
greater the possibility of introducing appropriate therapeu-
tic interventions to prevent death. If high-risk factors had
been promptly recognized and the children had been
properly treated, it is possible that progression to profound
shock and death could have been prevented.
The selection of the cases at 7 different hospitals, which
could have health care resources of varying quality, may
have contributed to the deaths of the case patients.
The small number of cases in this study resulted in very
wide confidence intervals, including the variables strongly
associated (odds ratio$3) with death. This limitation also
prevented us from adjusting the data in a multivariate
logistic regression model. Our unadjusted analysis showed
Table 3 - Laboratory and imaging findings of children with severe dengue.
Variable Cases N (%) Controls N (%) Odds ratio 95% CI p-value
ALT $1000 U/L 1/12 (8.3) 1/70 (1.4) 6.27 0.36-107.78 0.206
AST $1000 U/L 2/12 (16.7) 3/73 (4.1) 4.67 0.69-31.45 0.114
Hematocrit .45% 3/12 (25.0) 21/77 (27.3) 0.89 0.22-3.60 0.869
Leukocyte count .10 000/mm3 5/12 (41.7) 13/77 (16.9) 3.52 0.96-12.82 0.057
Platelet count
,150 000/mm3 11/14 (78.6) 73/77 (94.8) 0.20 0.04-1.02 0.053
,100 000/mm3 11/14 (78.6) 61/77 (79.2) 0.96 0.24-3.86 0.956
,50 000/mm3 6/14 (42.9) 35/77 (45.5) 0.90 0.28-2.84 0.857
Findings on imaging exams
Ascites 7/8 (87.5) 36/54 (66.7) 3.50 0.40-30.66 0.258
Pleural effusion
on ultrasonography 5/8 (62.5) 39/54 (72.2) 0.64 0.14-3.02 0.574
on radiography 5/9 (55.6) 56/71 (78.9) 0.33 0.08-1.40 0.135
Thicker gallbladder wall 3/8 (37.5) 29/54 (53.7) 0.52 0.11-2.38 0.398
Plasma leakage criteria
Cavity effusion 17/18 (94.4) 69/74 (93.2) 1.23 0.13-11.25 0.853
Hemoconcentration 5/7 (71.4) 49/76 (64.5) 1.38 0.25-7.58 0.713
Serum albumin ,3.5 g/dL 7/7 (100.0) 64/70 (91.4) NCa NC NC
Serum protein ,6.0 g/dL 5/5 (100.0) 43/51 (84.3) NC NC NC
aNC = not calculated.
Table 4 - Association between clinical characteristics and death in children admitted to the Hospital of the Universidade
Federal do Maranha˜o with severe dengue.
Signs and symptoms Cases N (%) Controls N (%) Odds ratio 95% CI p-value
Cold extremities 3/5 (60.0) 14/77 (18.2) 6.75 1.03-44.26 0.047
Cyanosis 5/5 (100.0) 17/77 (22.1) NCa NC NC
Dehydration 4/5 (80.0) 53/77 (68.8) 1.81 0.19-17.08 0.604
Dyspnea 5/5 (100.0) 36/77 (46.7) NC NC NC
Edema 5/5 (100.0) 47/77 (61.0) NC NC NC
Lethargy 4/5 (80.0) 36/77 (46.7) 4.56 0.49-42.64 0.184
Persistent vomiting 0/5 (0.0) 11/77 (14.3) NC NC NC
Prostration 3/5 (60.0) 9/77 (11.7) 11.33 1.66-77.27 0.013
Restlessness 2/5 (40.0) 13/77 (16.9) 3.28 0.50-21.64 0.217
Shock 5/5 (100.0) 77/77 (100.0) NC NC NC
Bleeding (any kind) 5/5 (100.0) 77/77 (100.0) NC NC NC
Ecchymoses 2/5 (40.0) 13/77 (16.9) 3.28 0.50-21.24 0.217
Epistaxis 4/5 (80.0) 7/77 (9.1) 40.0 3.91-409.05 0.002
Gastrointestinal bleeding 5/5 (100.0) 41/77 (53.3) NC NC NC
Gum bleeding 1/5 (20.0) 10/77 (13.0) 1.67 0.17-16.54 0.659
Hemoptysis 2/5 (40.0) 1/77 (1.3) 50.67 3.53-726.74 0.004
Petechiae 4/5 (80.0) 54/77 (70.1) 1.70 0.18-16.08 0.642
Positive tourniquet test 1/2 (50.0) 15/31 (48.4) 1.07 0.06-18.62 0.965
aNC = not calculated.
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that severe bleeding manifested by hemoptysis was strongly
associated with death, providing additional support for the
revised WHO dengue case classification (21). However, the
finding that epistaxis and persistent vomiting were also
associated with death in children with severe dengue was
unexpected and deserves to be explored in future studies.
Because intensive care units are often limited in resource-
poor settings, any information that can help to distinguish
patients with severe dengue with a higher risk to progress to
death may be crucial.
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